Norway Bioanalytical Testing Services Market Size & Outlook
Norway bioanalytical testing services market, 2018-2030 (US$M)
Related Markets
Norway bioanalytical testing services market highlights
- The Norway bioanalytical testing services market generated a revenue of USD 19.8 million in 2023 and is expected to reach USD 34.2 million by 2030.
- The Norway market is expected to grow at a CAGR of 8.1% from 2024 to 2030.
- In terms of segment, small molecule was the largest revenue generating molecule in 2023.
- Large Molecule is the most lucrative molecule segment registering the fastest growth during the forecast period.
Bioanalytical testing services market data book summary
| Market revenue in 2023 | USD 19.8 million |
| Market revenue in 2030 | USD 34.2 million |
| Growth rate | 8.1% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | Thermo Fisher Scientific Inc, Icon PLC, Charles River Laboratories International Inc, Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Intertek Group PLC, Pace Analytical Services |
Other key industry trends
- In terms of revenue, Norway accounted for 0.5% of the global bioanalytical testing services market in 2023.
- Country-wise, Kuwait is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany bioanalytical testing services market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 428.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bioanalytical Testing Services Market Scope
Bioanalytical Testing Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway bioanalytical testing services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioanalytical testing services market will help companies and investors design strategic landscapes.
Small molecule was the largest segment with a revenue share of 59.6% in 2023. Horizon Databook has segmented the Norway bioanalytical testing services market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
Increased R&D investment is expected to drive Norway's bioanalytical testing services market. As new drugs or formulations are developed, there will be a greater need for bioanalytical testing to assess these new products' pharmacokinetics, bioavailability, and safety.
This can drive the demand for bioanalytical testing services from specialized laboratories. For instance, In April 2023, Next Pharma acquired Takeda's primary European chewable tablet manufacturing facility in Asker, Norway.
By acquiring a manufacturing site, Next Pharma will likely increase its production capacity for chewable tablets. This expansion in manufacturing output could lead to a higher demand for bioanalytical testing services to ensure the quality & compliance of the produced pharmaceuticals.
Reasons to subscribe to Norway bioanalytical testing services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway bioanalytical testing services market databook
-
Our clientele includes a mix of bioanalytical testing services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Norway bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway bioanalytical testing services market size, by molecule, 2018-2030 (US$M)
Norway Bioanalytical Testing Services Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
